Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.

MLA

Cheok, Kathleen P. L., et al. “Improved COVID-19 Outcomes in CAR-T Patients in the Age of Vaccination and Preemptive Pharmacotherapeutics.” Leukemia & Lymphoma, vol. 64, no. 12, Dec. 2023, pp. 2037–41. EBSCOhost, https://doi.org/10.1080/10428194.2023.2248329.

APA

Cheok, K. P. L., Kirkwood, A. A., Creasey, T., Tholouli, E., Chaganti, S., Mathew, A., Dulobdas, V., Irvine, D., Besley, C., Neil, L., Lown, R., Menne, T., Townsend, W., Kuhnl, A., O’Reilly, M., Sanderson, R., Sanchez, E., & Roddie, C. (2023). Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics. Leukemia & Lymphoma, 64(12), 2037–2041. https://doi.org/10.1080/10428194.2023.2248329

Chicago

Cheok, Kathleen P L, Amy A Kirkwood, Thomas Creasey, Eleni Tholouli, Sridhar Chaganti, Amrith Mathew, Vaishali Dulobdas, et al. 2023. “Improved COVID-19 Outcomes in CAR-T Patients in the Age of Vaccination and Preemptive Pharmacotherapeutics.” Leukemia & Lymphoma 64 (12): 2037–41. doi:10.1080/10428194.2023.2248329.